Emerald Health Therapeutics Inc. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

CA$22.3M

Net Income/Loss (FY2019)

-CA$111.9M

Total Assets (FY2019)

CA$156.6M

Total Equity (FY2019)

CA$103.2M

Cash Flows from Operating Activities (FY2019)

-CA$24.8M

Source: Emerald Health Therapeutics Inc. 20-F filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.